TNFSF10 and scleroderma: Previous studies revealed that TRAIL could regulate the expression of inflammatory cytokines and induce apoptosis of fibroblasts in fibrotic diseases including hepatic fibrosis, scleroderma, scar hypertrophy, and bleomycin-induced pulmonary fibrosis (15, 17, 30–33).